LAB TALK: Jennie Liu, left, research scientist, and Jason LaPorte, senior research associate for TriSalus Life Sciences, discuss the TriNav infusion system that will be tested to deliver treatments for pancreatic and liver tumors as part of a partnership with Lifespan Corp. / PBN PHOTO/MICHAEL SALERNO
Rhode Island’s largest hospital system is hoping that teaming up with a biotech company could help achieve a breakthrough in developing treatment options for liver and pancreatic tumors. Lifespan Corp. says its new partnership with the Colorado-based TriSalus Life Sciences is more than just about providing space for a tenant to do lab research. It’s…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
